Latest Europe News

Dimerix has activated the first clinical trial site in Japan for its pivotal Phase 3 ACTION3 study targeting FSGS, triggering a significant milestone payment from its Japanese partner FUSO Pharmaceutical.

8I Holdings Limited reported a net loss of S$1.09 million for FY2025, impacted by a sharp decline in investment gains due to global market volatility and new U.S. tariffs. The Group remains focused on a conservative, value-driven investment strategy despite challenging conditions.

HNG has consolidated its position in the school uniform sector by acquiring full ownership of Global Uniform Solutions and announcing a transformative acquisition of Trutex Group, setting the stage for significant growth across key markets.

European Lithium Ltd and Critical Metals Corp have updated the Tanbreez Rare Earth Project scoping study, incorporating feldspar and arfvedsonite alongside eudialyte, underpinning a robust $2.4–3.0 billion NPV and a 162% IRR over a 19-year mine life.

Euro Manganese has successfully closed a C$11.2 million financing round, attracting heavyweight investors including the European Bank for Reconstruction and Development and Eric Sprott. The funds will accelerate development of its Chvaletice Manganese Project, a critical European source of battery-grade manganese.

Goodman Group reports steady progress in Q3 FY25 with a robust $13.7 billion development pipeline and strong demand for logistics and data centre infrastructure, reaffirming its FY25 Operating EPS growth forecast of 9%.

Web Travel Group Limited has reported a robust 22% increase in total transaction value following its strategic demerger, yet earnings were weighed down by margin compression and operational costs. The company is recalibrating its strategy to stabilize margins and pursue ambitious growth targets.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

Prescient Therapeutics has reached a pivotal milestone by dosing the first patient in its Phase 2a clinical trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma (CTCL), aiming to evaluate safety and efficacy across multiple international sites.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Vulcan Energy has begun drilling the first new well for its Phase One Lionheart Project in Germany, marking a critical step toward expanding its renewable geothermal energy and lithium production capacity.

Sprintex has commissioned an upgraded manure processing system with Mest Water, setting the stage for a major trial at Van Drie Group farms that could unlock A$8.4 million in revenue. The company is also expanding its market reach with a new mobile system targeting smaller farms amid tightening EU ammonia regulations.